Maintrac® Customised Chemosensitivity Test
Some CTCs can hide in the blood stream for months or years before activating and forming a second tumour. Some CTCs may even resist treatment. This analyses how a person’s CTCs respond when exposed to a recommended chemotherapy regimen or botanical treatment. CTCs that die or survive exposure are said to be ‘sensitive’ or ‘resistant’ to the tested treatment, respectively.
Recommended therapies can now be tested. Each test is customised specifically for each patient by the requesting practitioner.
Test for Treatments can be used to:
- Analyse if a person’s CTCs are sensitive or resistant to a recommended treatment
- Assist practitioners in deciding on a treatment plan
- Increase confidence in the therapy’s ability to reduce cancer spread effectively
Maintrac® is a state-of-the-art German technology that detects, characterises and tests CTCs. It has been critically validated and published in peer reviewed journals for over 12 years. Maintrac® CTC tests are acknowledged and utilised by many universities, Oncologists and cancer clinics worldwide.